Clinical trial

Hepatic Arterial Chemoembolization With Cisplatin or Internal Radiation Therapy…

NCT00109954 · University of Pittsburgh, Other · Completed

Key facts

NCT number NCT00109954
Title Hepatic Arterial Chemoembolization With Cisplatin or Internal Radiation Therapy in Treating Patients With Advanced Liver Cancer That Cannot Be Removed By Surgery
Official title A Prospectively Randomized Controlled Clinical Trial Comparing TheraSphere With Cisplatin-Based TACE (Trans Arterial Chemo Embolization) in the Management of Advanced Stage, Unresectable Hepatocellular Carcinoma (HCC)
Lead sponsor University of Pittsburgh, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 3
Study type Interventional
Conditions Liver Cancer
Intervention type Drug, Radiation
Interventions cisplatin, brachytherapy, yttrium Y 90 glass microspheres
Enrollment 120
Start date Feb 1, 2005
Primary completion Dec 1, 2005
Completion Dec 1, 2005
First posted May 4, 2005
Last update posted Jan 18, 2016
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies